Tirzepatide
Dual GLP-1 / GIP receptor agonist
Dual GLP-1 / GIP receptor agonist for appetite control, glucose regulation, and sustained weight loss. Available in 10mg, 30mg, and 60mg vials.
People also buy
AOD-9604 - 10mg
AOD-9604 is a modified fragment of human growth hormone (hGH 176-191) that has been studied for its potential role in promoting fat breakdown (lipolysis) and inhibiting fat formation, without affecting blood sugar or tissue growth. For research use only.
SemaMelt
Semaglutide/Pyridoxine 10mg sublingual tablet
SemaTirzeMelt
Semaglutide + Tirzepatide sublingual tablet
TirzMelt
1 pill a day
Reta (GLP-3) (Reconstituted) - 60mg
Reconstituted at 60mg / 2mL
Tirz (GLP-2) (Reconstituted) - 60mg
Reconstituted at 60mg / 2mL
AOD-9604 (Reconstituted) - 10mg
Reconstituted at 10mg / 4mL
Lipo-C (Reconstituted) - 10ml
Lipo-C (Reconstituted) – 10ml is a research-grade metabolic support formulation studied for its role in supporting lipid metabolism an
References
- Tirzepatide - Peptide Center guide
- Tirzepatide for the Treatment of Obstructive Sleep Apnea and ObesityThe New England journal of medicine, 2024
- Tirzepatide Once Weekly for the Treatment of ObesityThe New England journal of medicine, 2022
- Tirzepatide for Obesity Treatment and Diabetes PreventionThe New England journal of medicine, 2025
- Tirzepatide as Compared with Semaglutide for the Treatment of ObesityThe New England journal of medicine, 2025
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 DiabetesThe New England journal of medicine, 2021
- Tirzepatide for Heart Failure with Preserved Ejection Fraction and ObesityThe New England journal of medicine, 2025
Ready to start with Tirzepatide?
Take our eligibility quiz to see if this treatment is right for you.
Start Intake